PetMed Express, Inc. ("PetMed" or the Company) is an online pet pharmacy based in the United States.

According to the law firm press release, the Complaint filed in this class action alleges that throughout the Class Period, the Company made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose: (1) that the Company was marketing dangerous and addictive animal drugs to humans; (2) that, as such, the Company is vulnerable to potential civil or criminal liability, as well as other regulatory action; (3) that, as a result of the foregoing, Google may halt the Company’s advertising activities; and (4) that, as a result of the foregoing, Defendants’ statements about PetMed’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

On November 27, 2017, the Court issued an Order appointing lead Plaintiff and Counsel and consolidating Cases. The consolidated Cases shall be identified as: “In re PetMed Express, Inc. Securities Litigation.”

This case was voluntarily dismissed on January 19, 2018.